These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 38728474)

  • 1. Development and assessment of an RNA editing-based risk model for the prognosis of cervical cancer patients.
    Zhu Z; Lu J
    Medicine (Baltimore); 2024 May; 103(19):e38116. PubMed ID: 38728474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multi-omics-based investigation of the prognostic and immunological impact of necroptosis-related mRNA in patients with cervical squamous carcinoma and adenocarcinoma.
    Zou J; Lin Z; Jiao W; Chen J; Lin L; Zhang F; Zhang X; Zhao J
    Sci Rep; 2022 Oct; 12(1):16773. PubMed ID: 36202899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of prognostic biomarkers for cervical cancer based on programmed cell death-related genes and assessment of their immune profile and response to drug therapy.
    Feng S; Wang Z; Zhang H; Hou B; Xu Y; Hao S; Lu Y
    J Gene Med; 2024 Jan; 26(1):e3643. PubMed ID: 38044747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prognostic signature based on immune-related genes for cervical squamous cell carcinoma and endocervical adenocarcinoma.
    Liu J; Wu Z; Wang Y; Nie S; Sun R; Yang J; Cheng W
    Int Immunopharmacol; 2020 Nov; 88():106884. PubMed ID: 32795900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a necroptosis-related prognostic gene signature associated with tumor immune microenvironment in cervical carcinoma and experimental verification.
    Sun K; Huang C; Li JZ; Luo ZX
    World J Surg Oncol; 2022 Oct; 20(1):342. PubMed ID: 36253777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and Validation of the Anoikis-Related Gene Signature as a Novel Prognostic Model for Cervical Squamous Cell Carcinoma, Endocervical Adenocarcinoma, and Revelation Immune Infiltration.
    Jin QQ; Mei J; Hong L; Wang R; Wu SY; Wang SL; Jiang XY; Yang YT; Yao H; Zhang WY; Zhu YT; Ying J; Tian L; Chen G; Zhou SG
    Medicina (Kaunas); 2023 Feb; 59(2):. PubMed ID: 36837559
    [No Abstract]   [Full Text] [Related]  

  • 7. A Novel Prognostic Risk Model for Cervical Cancer Based on Immune Checkpoint HLA-G-Driven Differentially Expressed Genes.
    Xu HH; Wang HL; Xing TJ; Wang XQ
    Front Immunol; 2022; 13():851622. PubMed ID: 35924232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N6-Methyladenosine-Related lncRNAs as potential biomarkers for predicting prognoses and immune responses in patients with cervical cancer.
    Zhang H; Kong W; Zhao X; Han C; Liu T; Li J; Song D
    BMC Genom Data; 2022 Jan; 23(1):8. PubMed ID: 35042477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Necroptosis-related lncRNA signature predicts prognosis and immune response for cervical squamous cell carcinoma and endocervical adenocarcinomas.
    Lin Z; Zou J; Sui X; Yao S; Lin L; Wang J; Zhao J
    Sci Rep; 2022 Sep; 12(1):16285. PubMed ID: 36175606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SQLE-a promising prognostic biomarker in cervical cancer: implications for tumor malignant behavior, cholesterol synthesis, epithelial-mesenchymal transition, and immune infiltration.
    Zhao YC; Li YF; Qiu L; Jin SZ; Shen YN; Zhang CH; Cui J; Wang TJ
    BMC Cancer; 2024 Sep; 24(1):1133. PubMed ID: 39261819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of S1PR2 is correlated with poor prognosis and immune infiltrates in cervical squamous cell carcinoma and endocervical adenocarcinoma.
    Zhang Y; Wang H; Lu J; Lv Q; Yun B; Ge Z; Yan L
    Int J Immunopathol Pharmacol; 2023; 37():3946320231178131. PubMed ID: 37232164
    [No Abstract]   [Full Text] [Related]  

  • 12. ZNF695, A Potential Prognostic Biomarker, Correlates with Im mune Infiltrates in Cervical Squamous Cell Carcinoma and Endoce rvical Adenocarcinoma: Bioinformatic Analysis and Experimental Verification.
    Ding X; Wan A; Qi X; Jiang K; Liu Z; Chen B
    Curr Gene Ther; 2024; 24(5):441-452. PubMed ID: 38441026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Prognostic Biomarkers for Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (CESC) Patients via Analysis of Competing Endogenous RNA (ceRNA) Network.
    Dong Y; Wen W; Yuan T; Liu L; Li X
    Dis Markers; 2023; 2023():1766080. PubMed ID: 36817087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel prognostic signature based on cancer stemness and metabolism-related genes for cervical squamous cell carcinoma and endocervical adenocarcinoma.
    Wang Y; Han Y; Jin L; Ji L; Liu Y; Lin M; Zhou S; Yang R
    Aging (Albany NY); 2024 Apr; 16(8):7293-7310. PubMed ID: 38656879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of a prognostic prediction model for cervical cancer patients treated with radical radiotherapy: a study based on TCGA database.
    He JY; Li ZM; Chen YT; Zhao BH; Yu C
    Transl Cancer Res; 2024 Apr; 13(4):1721-1736. PubMed ID: 38737688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional analysis of tumor-derived immunoglobulin lambda and its interacting proteins in cervical cancer.
    Wang J; Huang J; Ding H; Ma J; Zhong H; Wang F; Chen Y; Peng H
    BMC Cancer; 2023 Oct; 23(1):929. PubMed ID: 37784026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
    Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
    Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased expression of CLCA2 and the correlating with immune infiltrates in patients with cervical squamous cell carcinoma: A bioinformatics analysis.
    Yang X; Cao JL; Yang FN; Li XF; Tao LM; Wang F
    Taiwan J Obstet Gynecol; 2021 May; 60(3):480-486. PubMed ID: 33966732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of ferroptosis-related molecular subtypes and a methylation-related ferroptosis gene prognostic signature in cervical squamous cell carcinoma.
    Yu L; Gao Z; Li Z; Liu P; Gao Y; Liang G
    J Cancer Res Clin Oncol; 2023 Nov; 149(16):14673-14689. PubMed ID: 37584713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A nomogram based on A-to-I RNA editing predicting overall survival of patients with lung squamous carcinoma.
    Liu L; Liu J; Deng X; Tu L; Zhao Z; Xie C; Yang L
    BMC Cancer; 2022 Jun; 22(1):715. PubMed ID: 35768804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.